Search - tctmd.com

Displaying 561 - 580 of 633

Sort: Relevancy | Date

Presentation TCT 2014

Interatrial Septum Stenting in Idiopathic Pulmonary Hypertension

Presenter: Bagrat Alekyan

September 13, 2014

Presentation TCT 2014

Case #1: Primary PCI of Left Main in Cardiogenic Shock

Presenter: Ajay J. Kirtane, Subroto Mandal

September 13, 2014

Presentation TCT 2014

Welcome and Program Overview

Presenter: Alexandre Abizaid

September 13, 2014

Presentation TCT 2014

Role of New Oral Anticoagulants and New ADP Antagonists in ACS Patients

Presenter: Roxana Mehran, Mohamed Sobhy

September 13, 2014

Presentation TCT 2014

FDA Approval Process: PMA vs CE Mark

Presenter: Sigmund Silber

September 13, 2014

Presentation TCT 2014

Endovenous Reconstruction of Occlusive Iliocaval Disease

Presenter: Jose Luis Assad-Morell, Efrain Gaxiola, Vanessa Rubio

September 13, 2014

Presentation TCT 2014

TCT 688: One-Year Results of Transcatheter Aortic Valve Therapy for Failed Surgical Bioprostheses PARTNER II Valve-in-Valve Registry

Presenter: Patrick W. Serruys, E. Murat Tuzcu, Ian T. Meredith, Rakesh M. Suri

September 13, 2014

Presentation TCT 2014

TCT 688: One-Year Results of Transcatheter Aortic Valve Therapy for Failed Surgical Bioprostheses PARTNER II Valve-in-Valve Registry

Presenter: Patrick W. Serruys, E. Murat Tuzcu, Ian T. Meredith, Rakesh M. Suri

September 13, 2014

Presentation TCT 2014

Lessons from the PARTNER Trials

Presenter: Patrick W. Serruys, E. Murat Tuzcu, Ian T. Meredith

September 13, 2014

Presentation TCT 2014

Emerging Funding Models and International Partnerships

Presenter: Louis A. Cannon, Casey McGlynn, Peter J. Fitzgerald

September 13, 2014

Presentation TCT 2014

Updates from PARTNER 2A and Sapien 3 in Intermediate-Risk Patients

Presenter: Martin B. Leon, Neil E. Moat, Ariel Finkelstein, Vinod H. Thourani

September 13, 2014

Presentation TCT 2014

PARTNER I: Five-Year Results From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Balloon-Expandable Device Versus Conservative Care in Extremely High-Risk Patients with Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen, Samir R. Kapadia

September 13, 2014

News Conference News TCT 2014

PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients

Yael L. Maxwell

September 13, 2014

News Conference News TCT 2014

Michael J. Mack, MD, Becomes First Surgeon to Receive TCT Career Achievement Award

September 13, 2014

Presentation TCT 2013

Lessons Learned from PARTNER 2A and SURTAVI: Device Specificity, Trial Design, Endpoints, and Future Low-risk Studies

Presenter: Jodi Akin

October 30, 2013

News Conference News TCT 2013

Two Trials to Assess TAVR in Moderate-Risk Patients

October 30, 2013

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

News Conference News TCT 2013

Need, Potential Exist for Global Integrated Regulatory Approach in Cardiology

October 30, 2013

Presentation TCT 2013

Transcatheter Aortic Valve Replacement: Assessment of the Learning Curve Based on the PARTNER Trial

Presenter: Oluseun Alli

October 29, 2013

Presentation TCT 2013

TCT-117. Quality of Life Outcomes Among High-Risk Patients Undergoing TAVR via the Transapical Approach: A PARTNER Continued Access Substudy

Presenter: Ajay Kirtane

October 29, 2013

Advertisement

Interatrial Septum Stenting in Idiopathic Pulmonary Hypertension

Case #1: Primary PCI of Left Main in Cardiogenic Shock

Welcome and Program Overview

Role of New Oral Anticoagulants and New ADP Antagonists in ACS Patients

FDA Approval Process: PMA vs CE Mark

Endovenous Reconstruction of Occlusive Iliocaval Disease

TCT 688: One-Year Results of Transcatheter Aortic Valve Therapy for Failed Surgical Bioprostheses PARTNER II Valve-in-Valve Registry

TCT 688: One-Year Results of Transcatheter Aortic Valve Therapy for Failed Surgical Bioprostheses PARTNER II Valve-in-Valve Registry

Lessons from the PARTNER Trials

Emerging Funding Models and International Partnerships

Updates from PARTNER 2A and Sapien 3 in Intermediate-Risk Patients

PARTNER I: Five-Year Results From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Balloon-Expandable Device Versus Conservative Care in Extremely High-Risk Patients with Aortic Stenosis

PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients

Michael J. Mack, MD, Becomes First Surgeon to Receive TCT Career Achievement Award

Lessons Learned from PARTNER 2A and SURTAVI: Device Specificity, Trial Design, Endpoints, and Future Low-risk Studies

Two Trials to Assess TAVR in Moderate-Risk Patients

Innovation in Intervention: Perspectives from Industry

Need, Potential Exist for Global Integrated Regulatory Approach in Cardiology

Transcatheter Aortic Valve Replacement: Assessment of the Learning Curve Based on the PARTNER Trial

TCT-117. Quality of Life Outcomes Among High-Risk Patients Undergoing TAVR via the Transapical Approach: A PARTNER Continued Access Substudy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content